Skip to main content
. 2023 May 10;15(10):2252. doi: 10.3390/nu15102252

Table 4.

Generalized Estimating Equation (GEE): expected values for different markers by time and degree of NAFLD severity.

Glucose Insulin Homa-IR Hb1Ac
β 95% CI β 95% CI β 95% CI β 95% CI
Follow-up
Baseline 0.00 0.00 0.00 0.00
3 month −4.65 −9.74; 0.44 −2.39 * −4.50; −0.28 −0.59 −1.28; 0.09 −1.93 * −3.59; −0.27
6 month −3.74 −9.05; 1.57 −1.72 −3.88; 0.44 −0.39 −1.09; 0.31 −3.84 ** −5.55; −2.13
9 month −8.56 ** −14.34; −2.77 −0.91 −3.38; 1.57 −0.39 −1.16; 0.39 −4.80 ** −6.68; −2.91
12 month −8.54 ** −15.15; −1.94 −1.82 −4.62; 0.99 −0.72 −1.57; 0.13 −5.41 ** −7.51; −3.32
NAFLD
Absent 0.00 0.00 0.00 0.00
Mild −3.47 −9.73; 2.78 0.96 −1.26; 3.17 0.23 −0.44; 0.89 −1.72 −3.80; 0.36
Moderate −0.11 −6.32; 6.09 2.39 −0.02; 4.80 0.92 ** 0.19; 1.66 −1.14 −3.23; 0.95
Severe 10.29 * 1.89; 18.68 2.28 −1.13; 5.69 1.35 * 0.22; 2.47 0.32 −2.46; 3.09

Adjusted for age, sex and BMI ** p < 0.001 * p < 0.05. Homa-IR: Homeostatic Model Assessment for Insulin Resistance; HbA1c: Glycosylated Haemoglobin; NAFLD: Non-Alcoholic Fatty Liver Disease.